Autolus Therapeutics (AUTL) Non Operating Interest Expenses (2021 - 2026)
Autolus Therapeutics (AUTL) recorded Non Operating Interest Expenses of -$2.67 million in Q2 2026, compared with -$6.83 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends
On a TTM basis, Autolus Therapeutics' Non Operating Interest Expenses came in at $23.85 million as of Jun 30, 2026; for FY2025, it came in at $36.67 million, up 294.6% from FY2024.
- Annual Non Operating Interest Expenses has a four-year compound annual growth rate of 140.0% (FY2021 to FY2025).
- Across earlier years, Non Operating Interest Expenses came in at $9.29 million in FY2024 (-79.4%), $45.07 million in FY2023 (+406.1%), $8.91 million in FY2022 (+705.9%) and $1.11 million in FY2021.
- Quarterly Non Operating Interest Expenses has ranged from -$30.84 million in Q4 2024 to $30.13 million in Q4 2023 over the past five years.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 771.5% in Q4 2023, against a decline of 47.4% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Autolus Therapeutics | 688.78 Mn | -635.30 Mn | 25.22 Mn | -2.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.67 Mn |
| Dec 31, 2025 | 22.84 Mn |
| Sep 30, 2025 | 10.52 Mn |
| Jun 30, 2025 | -6.83 Mn |
| Mar 31, 2025 | 10.14 Mn |
| Dec 31, 2024 | -30.84 Mn |
| Sep 30, 2024 | 10.69 Mn |
| Jun 30, 2024 | 10.17 Mn |
| Mar 31, 2024 | 19.27 Mn |
| Dec 31, 2023 | 30.13 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 5.02 Mn |
| Mar 31, 2023 | 4.91 Mn |
| Dec 31, 2022 | 3.46 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.11 Mn |
API Access
Autolus Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();